O. V. Riabokon, V. V. Cherkaskyi, Yu. Yu. Riabokon, R. O. Shcherbyna
{"title":"新冠肺炎氧依赖患者细胞因子调节参数的临床及预后价值","authors":"O. V. Riabokon, V. V. Cherkaskyi, Yu. Yu. Riabokon, R. O. Shcherbyna","doi":"10.14739/2310-1237.2023.2.283531","DOIUrl":null,"url":null,"abstract":"Aim of the work is to find out the clinical and prognostic significance of cytokine regulation parameters in oxygen-dependent patients with COVID-19 coronavirus disease in dynamics of the disease. Material and methods. 78 oxygen-dependent patients with COVID-19 aged from 52 to 84 years were examined. All patients were examined and treated in accordance with the regulations in force at the relevant time. The patients were divided into groups: I group – 38 patients who recovered; II group – 40 patients with fatal outcome of the disease. In the blood serum of patients with COVID-19 and 20 healthy individuals, were determined by enzyme immunoassay the content of interleukin (IL) IL-2 (Elabscience, USA), IL-4 (Affymetrix eBioscience, Austria), IL-6 (Invitrogen, Austria), monocyte chemotactic protein-1 (MCP-1) (Elabscience, USA). Statistical processing was performed in the Statistica 13 for Windows program (StatSoft Inc., No. JPZ804I382130ARCN10-J). Results. The content of IL-2 in the blood serum of oxygen-dependent patients with COVID-19 of both groups was significantly higher (p < 0.001) than in healthy individuals. IL-2 content was higher in patients of II group (p < 0.001) than in patients of I group. In dynamics, a further increase in content of IL-2 was noted in patients of the II group (р < 0.05). The diagnostic significance has been established of the increased level of IL-2 in assessing the high probability of the development of a fatal outcome of the disease during hospitalization (AUC = 0.698, p = 0.030) and in the dynamics of treatment (AUC = 0.745, p = 0.015). The content of IL-6 in the blood serum of oxygen-dependent patients with COVID-19 of both groups was also significantly higher (p < 0.001) than in healthy individuals. However, the level of increase of this cytokine at the time of hospitalization did not have prognostic value regarding the risk of fatal outcome (AUC = 0.539, p = 0.562). In the dynamics of treatment, the content of IL-6 in blood serum continued to increase in patients of the II group (p < 0.01). During this period of observation, a threshold level of increase IL-6 level was established, which indicates a high probability of the development of a fatal outcome in these patients (AUC = 0.850, p < 0.001). The content of chemokine MCP-1 in blood serum at the time of hospitalization in patients of both groups was higher (p < 0.01) than in healthy people. At the same time, the content of MCP-1 in patients of the II group was higher (p < 0.05) than in the patients of the I group. The diagnostic significance of the increased level of MCP-1 was established, which indicated a high probability of the development of a fatal outcome during hospitalization. In dynamics, there was a tendency (p > 0.05) to decrease its content (p > 0.05), however, during this period of observation, MCP-1 did not have prognostic value. IL-4 turned out to be uninformative in prognostic terms for determining the probability of a fatal outcome of COVID-19. Conclusions. Changes in the parameters of cytokine regulation in patients with COVID-19 during the development of oxygen dependence are characterized by a significant increase content of IL-2, IL-6 and chemokine MCP-1 in blood serum. The level of increase of these cytokines has diagnostic value in determining the high probability of the development of a fatal outcome of the disease at certain stages of observation.","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"115 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical and prognostic value of parameters of cytokine regulation in oxygen-dependent patients with the coronavirus disease COVID-19\",\"authors\":\"O. V. Riabokon, V. V. Cherkaskyi, Yu. Yu. Riabokon, R. O. Shcherbyna\",\"doi\":\"10.14739/2310-1237.2023.2.283531\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim of the work is to find out the clinical and prognostic significance of cytokine regulation parameters in oxygen-dependent patients with COVID-19 coronavirus disease in dynamics of the disease. Material and methods. 78 oxygen-dependent patients with COVID-19 aged from 52 to 84 years were examined. All patients were examined and treated in accordance with the regulations in force at the relevant time. The patients were divided into groups: I group – 38 patients who recovered; II group – 40 patients with fatal outcome of the disease. In the blood serum of patients with COVID-19 and 20 healthy individuals, were determined by enzyme immunoassay the content of interleukin (IL) IL-2 (Elabscience, USA), IL-4 (Affymetrix eBioscience, Austria), IL-6 (Invitrogen, Austria), monocyte chemotactic protein-1 (MCP-1) (Elabscience, USA). Statistical processing was performed in the Statistica 13 for Windows program (StatSoft Inc., No. JPZ804I382130ARCN10-J). Results. The content of IL-2 in the blood serum of oxygen-dependent patients with COVID-19 of both groups was significantly higher (p < 0.001) than in healthy individuals. IL-2 content was higher in patients of II group (p < 0.001) than in patients of I group. In dynamics, a further increase in content of IL-2 was noted in patients of the II group (р < 0.05). The diagnostic significance has been established of the increased level of IL-2 in assessing the high probability of the development of a fatal outcome of the disease during hospitalization (AUC = 0.698, p = 0.030) and in the dynamics of treatment (AUC = 0.745, p = 0.015). The content of IL-6 in the blood serum of oxygen-dependent patients with COVID-19 of both groups was also significantly higher (p < 0.001) than in healthy individuals. However, the level of increase of this cytokine at the time of hospitalization did not have prognostic value regarding the risk of fatal outcome (AUC = 0.539, p = 0.562). In the dynamics of treatment, the content of IL-6 in blood serum continued to increase in patients of the II group (p < 0.01). During this period of observation, a threshold level of increase IL-6 level was established, which indicates a high probability of the development of a fatal outcome in these patients (AUC = 0.850, p < 0.001). The content of chemokine MCP-1 in blood serum at the time of hospitalization in patients of both groups was higher (p < 0.01) than in healthy people. At the same time, the content of MCP-1 in patients of the II group was higher (p < 0.05) than in the patients of the I group. The diagnostic significance of the increased level of MCP-1 was established, which indicated a high probability of the development of a fatal outcome during hospitalization. In dynamics, there was a tendency (p > 0.05) to decrease its content (p > 0.05), however, during this period of observation, MCP-1 did not have prognostic value. IL-4 turned out to be uninformative in prognostic terms for determining the probability of a fatal outcome of COVID-19. Conclusions. Changes in the parameters of cytokine regulation in patients with COVID-19 during the development of oxygen dependence are characterized by a significant increase content of IL-2, IL-6 and chemokine MCP-1 in blood serum. The level of increase of these cytokines has diagnostic value in determining the high probability of the development of a fatal outcome of the disease at certain stages of observation.\",\"PeriodicalId\":41645,\"journal\":{\"name\":\"Pathologia\",\"volume\":\"115 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14739/2310-1237.2023.2.283531\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14739/2310-1237.2023.2.283531","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
本研究旨在探讨细胞因子调节参数在COVID-19冠状病毒病氧依赖患者发病动力学中的临床及预后意义。材料和方法。对78例52 ~ 84岁的新冠肺炎氧依赖患者进行了检查。所有患者均按照当时有效的规定进行检查和治疗。将患者分为两组:ⅰ组38例患者痊愈;II组- 40例有死亡结局的患者。采用酶免疫分析法测定新冠病毒患者和20名健康人血清中白细胞介素(IL) IL-2 (Elabscience,美国)、IL-4 (Affymetrix eBioscience,奥地利)、IL-6 (Invitrogen,奥地利)、单核细胞趋化蛋白-1 (MCP-1) (Elabscience,美国)的含量。统计处理在Statistica 13 for Windows程序中进行(StatSoft Inc., No. 5)。JPZ804I382130ARCN10-J)。结果。两组COVID-19氧依赖患者血清IL-2含量均显著升高(p <0.001)。II组患者IL-2含量较高(p <0.001)。在动力学上,II组患者IL-2含量进一步增加(p < 0.05)。0.05)。IL-2水平升高在评估住院期间疾病发生致命结局的高概率(AUC = 0.698, p = 0.030)和治疗动态(AUC = 0.745, p = 0.015)方面具有诊断意义。两组氧依赖患者血清IL-6含量均显著升高(p <0.001)。然而,住院时该细胞因子的升高水平对死亡结局的风险没有预后价值(AUC = 0.539, p = 0.562)。在治疗动态中,II组患者血清中IL-6含量持续升高(p <0.01)。在此期间,IL-6水平升高的阈值水平被建立,这表明这些患者发生致命结局的概率很高(AUC = 0.850, p <0.001)。两组患者住院时血清趋化因子MCP-1含量均较高(p <0.01)。同时,II组患者MCP-1含量较高(p <p < 0.05)。MCP-1水平升高的诊断意义被确立,这表明住院期间发生致命结局的概率很高。在动力学方面,有一种趋势(p >0.05)降低其含量(p >0.05),但在观察期间,MCP-1无预后价值。事实证明,在确定COVID-19致命结果的概率方面,IL-4不能提供预后方面的信息。结论。COVID-19患者在氧依赖发展过程中细胞因子调节参数的变化以血清IL-2、IL-6和趋化因子MCP-1含量显著升高为特征。在观察的某些阶段,这些细胞因子的增加水平在确定疾病发展为致命结果的高概率方面具有诊断价值。
Clinical and prognostic value of parameters of cytokine regulation in oxygen-dependent patients with the coronavirus disease COVID-19
Aim of the work is to find out the clinical and prognostic significance of cytokine regulation parameters in oxygen-dependent patients with COVID-19 coronavirus disease in dynamics of the disease. Material and methods. 78 oxygen-dependent patients with COVID-19 aged from 52 to 84 years were examined. All patients were examined and treated in accordance with the regulations in force at the relevant time. The patients were divided into groups: I group – 38 patients who recovered; II group – 40 patients with fatal outcome of the disease. In the blood serum of patients with COVID-19 and 20 healthy individuals, were determined by enzyme immunoassay the content of interleukin (IL) IL-2 (Elabscience, USA), IL-4 (Affymetrix eBioscience, Austria), IL-6 (Invitrogen, Austria), monocyte chemotactic protein-1 (MCP-1) (Elabscience, USA). Statistical processing was performed in the Statistica 13 for Windows program (StatSoft Inc., No. JPZ804I382130ARCN10-J). Results. The content of IL-2 in the blood serum of oxygen-dependent patients with COVID-19 of both groups was significantly higher (p < 0.001) than in healthy individuals. IL-2 content was higher in patients of II group (p < 0.001) than in patients of I group. In dynamics, a further increase in content of IL-2 was noted in patients of the II group (р < 0.05). The diagnostic significance has been established of the increased level of IL-2 in assessing the high probability of the development of a fatal outcome of the disease during hospitalization (AUC = 0.698, p = 0.030) and in the dynamics of treatment (AUC = 0.745, p = 0.015). The content of IL-6 in the blood serum of oxygen-dependent patients with COVID-19 of both groups was also significantly higher (p < 0.001) than in healthy individuals. However, the level of increase of this cytokine at the time of hospitalization did not have prognostic value regarding the risk of fatal outcome (AUC = 0.539, p = 0.562). In the dynamics of treatment, the content of IL-6 in blood serum continued to increase in patients of the II group (p < 0.01). During this period of observation, a threshold level of increase IL-6 level was established, which indicates a high probability of the development of a fatal outcome in these patients (AUC = 0.850, p < 0.001). The content of chemokine MCP-1 in blood serum at the time of hospitalization in patients of both groups was higher (p < 0.01) than in healthy people. At the same time, the content of MCP-1 in patients of the II group was higher (p < 0.05) than in the patients of the I group. The diagnostic significance of the increased level of MCP-1 was established, which indicated a high probability of the development of a fatal outcome during hospitalization. In dynamics, there was a tendency (p > 0.05) to decrease its content (p > 0.05), however, during this period of observation, MCP-1 did not have prognostic value. IL-4 turned out to be uninformative in prognostic terms for determining the probability of a fatal outcome of COVID-19. Conclusions. Changes in the parameters of cytokine regulation in patients with COVID-19 during the development of oxygen dependence are characterized by a significant increase content of IL-2, IL-6 and chemokine MCP-1 in blood serum. The level of increase of these cytokines has diagnostic value in determining the high probability of the development of a fatal outcome of the disease at certain stages of observation.